A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia [16]

Leukemia

Volumn 21, Issue 9, 2007, Pages 2072-2074

  Yang, J ^a   Liu, J ^a   Zheng, J ^a   Du, W ^a   He, Y ^a   Liu, W ^a   Huang, S ^a  

^a UNION HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LEUKEMIA; BLAST CELL; FLOW CYTOMETRY; HUMAN; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; WESTERN BLOTTING;

EID: 34548133593     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404740     Document Type: Letter

References (8)

1. Grandage VL, Gale RE, Linch DC, Khwaja A. P13-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia 2005; 19: 586-594.
2. Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C et al. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 2006; 20: 911-928.
3. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G et al. Promoter hypermethylation of cancer-related genes: A strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004; 104: 2492-2498.
4. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006; 441: 518-522.
5. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H et al. PTEN dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441: 475-482.
6. Cheong JW, Eom JI, Maeng HY, Lee ST, Hahn JS, Ko YW et al. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome. Br J Haematol 2003; 122 454-456.
7. Min YH, Cheong JW, Lee MH, Kim JY, Lee ST, Hahn JS et al. Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: Its association with constitutive phosphorylation of phosphatase and tensin homologue protein and poor prognosis. Clin Cancer Res 2004; 10: 5123-5130.
8. Zhou M, Gu L, Findley HW, Jiang R, Woods WG. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells. Cancer Res 2003; 63: 6357-6362.